Khiron
Khiron Life Sciences Corp is a publicly traded (TSX-V: KHRN) medical cannabis company operating Zerenia integrative-medicine clinics in Colombia, exporting pharmaceutical-grade cannabis products to seven countries, and training prescribers via Khiron Academy, with GMP manufacturing in Germany through its Pharmadrug Production GmbH subsidiary.
- Company typePublic
- Founded2012
- HeadquartersBogotá, Colombia
- Headcount101–250
- GTM typeB2C
- OfferingServices
What Khiron does
Khiron Life Sciences Corp (TSX-V: KHRN) is a publicly traded medical cannabis company headquartered in Bogotá, Colombia, with operational reach across Colombia, Germany, the United Kingdom, Peru, Brazil, Canada, and Australia. Founded in 2012 and currently employing 101–250 staff, the company runs a vertically integrated model that combines clinical care, pharmaceutical manufacturing, and medical education. Its core delivery vehicle is the Zerenia clinic network, which applies an integrative medicine framework to prescribe medical cannabis, supported by the Doctor Zerenia telehealth sub-brand and the ILANS health services brand; an online physician education platform, Khiron Academy, trains healthcare professionals on cannabis prescription.
Underlying the clinical operation is a pharmaceutical product line marketed under the Khiron Med brand, distributed directly in Germany and the UK. In August 2022 Khiron acquired Pharmadrug Production GmbH, a German pharmaceutical manufacturer and distributor with a GMP-certified facility, giving the company direct supply chain control in Europe and access to pharmaceutical-grade medical cannabis production. Combined with low-cost Colombian cultivation (equatorial climate, volcanic soil, lower labor costs), this German GMP footprint allows Khiron to export cannabis oil and flower competitively into multiple international markets.
The business generates revenue across three streams: (i) pharmaceutical cannabis product sales through health centers and international distribution (hardware-style sales), (ii) clinical and health services revenue from Zerenia consultations and treatment programs (professional services), and (iii) revenue from the Khiron Academy education platform (recurring/subscription). Customer segments are split between individual patients seeking medical cannabis therapy at Zerenia clinics (primary segment) and healthcare professionals requiring training and prescription guidance (secondary). GTM is primarily enterprise field sales combined with a sales-led distribution model, with direct operations offices and pharmacovigilance support lines in each served market. The company has disclosed cumulative funding of roughly C$25–30M across rounds in 2018, 2021, 2022, and 2023, and reports persistent negative EBITDA through 2021, indicating an early-scale operator still building toward profitability.
Khiron firmographics
Firmographics- Name
- Khiron
- Legal name
- Khiron Life Sciences Corp
- Website
- https://khiron.ca
- Company type
- Public
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Khiron Life Sciences Corp is a publicly traded (TSX-V: KHRN) medical cannabis company operating Zerenia integrative-medicine clinics in Colombia, exporting pharmaceutical-grade cannabis products to seven countries, and training prescribers via Khiron Academy, with GMP manufacturing in Germany through its Pharmadrug Production GmbH subsidiary.
- Ownership category
- akta.pro rank
Khiron industry classification
Industry- Product category
- Medical Cannabis Healthcare
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541), Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
- akta.pro secondary industries
- Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail) (CRANAFAG), Medical Cannabis Delivery & Online Ordering (CRANAGAG), Cannabis Accessories & Smoke Shops (Pipes, Papers, Grinders) (CRANAHAG)
Keywords
Where Khiron is headquartered
LocationHeadquarters
- HQ city
- Bogotá
- HQ country
- Colombia
- HQ region
- Latin America
Offices6 records
Markets served
Khiron business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Medical Cannabis Pharmaceutical Products: Development and sale of high-quality pharmaceutical cannabis products through health center network and international distribution
- Health Services: Revenue from integrative medicine health centers (Zerenia clinics) providing patient consultations and treatment programs
- Medical Education Programs: Khiron Academy provides training and education for health professionals on medical cannabis prescription
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Khiron product offering
Product offeringCore offering
Khiron Life Sciences Corp develops, manufactures, and distributes pharmaceutical-grade medical cannabis products under the Khiron Med brand in Germany and the UK, while operating a network of integrative medicine health centers (Zerenia and Doctor Zerenia) that provide direct patient consultations and medical cannabis prescriptions in Colombia. The company also delivers medical cannabis education and training to healthcare professionals through Khiron Academy.
Product overview
Khiron Life Sciences Corp is a pureplay health and wellbeing company focused on the global medical cannabis market. The company operates a platform-plus-brands model consisting of Khiron Med (its core medical cannabis product line), Khiron Academy (medical education platform), and several health center sub-brands including Zerenia clinics, Doctor Zerenia digital health services, and ILANS wellness services. The company also acquired Pharmadrug Production GmbH to establish a European pharmaceutical distribution hub with GMP-certified manufacturing capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- Zerenia: Health clinic brand offering integrative medicine and medical cannabis treatments
- Doctor Zerenia
- Ilans
- Khiron Med (Germany)
- Khiron Med (UK)
Products and services
- Khiron Med (Germany) Pharmaceutical-grade medical cannabis product brand serving patients in the German market through GMP-certified manufacturing operations.
- Khiron Med (UK) Medical cannabis product brand serving patients in the UK market through Khiron Med distribution.
- Khiron Academy Online medical education platform providing training programs, clinical cases, and real-life examples for health professionals on medical cannabis prescription and clinical applications.
- Zerenia Health Centers Network of integrative medicine health centers providing patient consultations, medical cannabis prescriptions, and ongoing treatment through the Patient Follow-up Program in Colombia.
- Doctor Zerenia Digital health service platform providing patients access to medical cannabis prescriptions and ongoing treatment monitoring.
- ILANS Health services brand providing integrative medicine and wellness services.
Quantifiable outcome
- Supply chain control in Germany enabling increased gross margins
- +1 more outcomes
Companies that use Khiron
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles3 records
Khiron technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Khiron partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Pharmadrug Production GmbHcoreKhiron completed the acquisition of Pharmadrug Production GmbH, a German pharmaceutical manufacturer and distributor with GMP-certified facility. This acquisition establishes Khiron's European pharmaceutical distribution hub for medical cannabis and other products, providing direct control of supply chain in Germany and expanding the company's medical cannabis product portfolio with increased gross margins.
Scale indicators4 records
Recent moves5 records
Expansion highlights6 records
Khiron competitors and assessment
Company assessmentDirect peers
- Clever Leaves: Colombian-based medical cannabis cultivator and exporter with GMP-certified operations serving international markets — directly comparable to Khiron's Colombia-to-international export model.
- Avicanna: Canadian-listed cannabis pharmaceutical company with significant Colombian operations and a focus on medical cannabis products — overlapping with Khiron's pharma-grade cannabis and Latin American footprint.
- Flora Growth: Colombian-headquartered cannabis cultivator and consumer products company — directly comparable geography and export orientation to Khiron's core Latin American operation.
- OrganiGram Holdings: Canadian medical and recreational cannabis producer with international medical cannabis distribution — comparable product mix and cross-border medical export strategy to Khiron Med.
- Cresco Labs: US multi-state cannabis operator with a strong focus on medical cannabis retail and wholesale brands — comparable medical-cannabis-first orientation and brand-led strategy to Khiron.
Emerging players
- Charlotte's Web Holdings: Vertically integrated hemp-derived CBD wellness company selling through health and wellness channels — comparable wellness/medical-cannabis-adjacent positioning, though focused on hemp-derived rather than pharmaceutical-grade cannabis.
Broad incumbents
- Tilray Brands: Large global cannabis company with medical cannabis operations in Germany, Portugal and Canada — competes with Khiron in European medical cannabis distribution and GMP-certified supply.
- Canopy Growth: Major diversified cannabis company with international medical cannabis platforms including Germany — overlaps with Khiron's medical export model and German distribution ambitions.
- Aurora Cannabis: Canadian cannabis producer with established European medical cannabis distribution through Aurora Europe — comparable international medical export footprint to Khiron.
- Cronos Group: Global cannabis company with medical cannabis operations in multiple jurisdictions including Israel and Germany — competes broadly with Khiron in international medical cannabis markets.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights5 records
Customer concentration
Khiron social profiles
Digital presenceKhiron compliance and trust
Trust signalCompliance1 record
Khiron financial estimates
Financial estimateRevenue estimate
Valuation estimate
Khiron leadership team
Management profileNumber of profiles
Profiles2 records
Khiron subsidiaries and ownership
Company hierarchySubsidiaries1 record
Khiron funding detail
Funding detailFunding overview
Funding rounds4 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Khiron M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Khiron
What does Khiron do?
Khiron Life Sciences Corp develops, manufactures, and distributes pharmaceutical-grade medical cannabis products under the Khiron Med brand in Germany and the UK, while operating a network of integrative medicine health centers (Zerenia and Doctor Zerenia) that provide direct patient consultations and medical cannabis prescriptions in Colombia. The company also delivers medical cannabis education and training to healthcare professionals through Khiron Academy.
Is Khiron a public or private company?
Khiron is a public company. It is classified as public and is currently operating.
When was Khiron founded?
Khiron was founded in 2012. It employs 101 to 250 people.
Where is Khiron based?
Khiron is headquartered in Bogotá, Colombia, in the Latin America region.
How does Khiron make money?
Three revenue lines are on record. Medical Cannabis Pharmaceutical Products are the primary driver. The others are health Services and medical Education Programs.
Who are Khiron's main competitors?
Direct peers on record are Clever Leaves, Avicanna, Flora Growth, OrganiGram Holdings and Cresco Labs. Charlotte's Web Holdings is listed as an emerging player. Broad incumbents are Tilray Brands, Canopy Growth, Aurora Cannabis and Cronos Group.
Does Khiron have an API?
No public API is recorded for Khiron.
What industry is Khiron in?
Khiron's product category is Medical Cannabis Healthcare. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services), with a secondary code of CRANAFAG, Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail). Its NAICS code is 32541 and its SIC code is 2833.